Main Industry
Hardware
Main Product/Service
Hydrogen Coral Calcium Capsules and Molecular Modeling Platform Services
Founded Year
2017
Unified Business No.
52895330
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,150,260 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
HoHo Biotech was founded in 2017. The company focuses on hydrogen-based molecular medicine and gut microenvironment research. In 2018, it developed a proprietary natural coral calcium material. In 2020, it received TFDA approval as a health supplement and began initial human clinical trials. In 2022, it launched multicenter clinical studies. In 2024, HoHo introduced an AI molecular simulation system and built the Molecular Intelligence Engine, combining functional material science with computational modeling. In 2025, it launched HydroChat, an AI assistant for personalized applications. This development led to the company’s core strategy, Gut Engineering, which uses molecular signals to regulate the intestinal environment.
